Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Two separate charges
Side Effects & Safety Considerations The adverse event profile of MOUNJARO (tirzepatide) is predominantly gastrointestinal, aligning with the incretin receptor agonist class, with frequency and severity correlating to dose and titration speed.[3][4] Most common reactions include nausea, diarrhea, vomiting, abdominal pain, constipation, dyspepsia, and decreased appetite.[3][4] These effects are typically mild-to-moderate, peak during dose escalation, and lessen over time on a stable dose.[3] If tolerability is significantly compromised, providers should consider delaying escalation or extending the current dose interval
Retatrutide is still in clinical trials, so its full safety profile is not yet known
Benefits of Compounded Semaglutide Found members using GLP-1 injections as part of a full Found program have reported losing up to 16% of their body weight in 12 months.* Results depend on dose, duration, and how closely you follow your care plan
It tells your brain you are full, slows down how fast your stomach empties, and helps your pancreas release the right amount of insulin
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
